JP2005532364A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532364A5 JP2005532364A5 JP2004512754A JP2004512754A JP2005532364A5 JP 2005532364 A5 JP2005532364 A5 JP 2005532364A5 JP 2004512754 A JP2004512754 A JP 2004512754A JP 2004512754 A JP2004512754 A JP 2004512754A JP 2005532364 A5 JP2005532364 A5 JP 2005532364A5
- Authority
- JP
- Japan
- Prior art keywords
- gatifloxacin
- degrees
- crystalline form
- solution
- exposure time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 claims description 29
- 229960003923 gatifloxacin Drugs 0.000 claims description 18
- 238000002441 X-ray diffraction Methods 0.000 claims description 5
- 238000010586 diagram Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- RMJMZKDEVNTXHE-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;trihydrate Chemical compound O.O.O.FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCNC(C)C1.FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCNC(C)C1 RMJMZKDEVNTXHE-UHFFFAOYSA-N 0.000 claims description 4
- 238000001938 differential scanning calorimetry curve Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- 238000001816 cooling Methods 0.000 claims 5
- 239000002002 slurry Substances 0.000 claims 3
- 239000000725 suspension Substances 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 230000014759 maintenance of location Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000010992 reflux Methods 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 238000002955 isolation Methods 0.000 claims 1
- 238000010899 nucleation Methods 0.000 claims 1
- 238000001757 thermogravimetry curve Methods 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38909302P | 2002-06-14 | 2002-06-14 | |
| US42333802P | 2002-11-01 | 2002-11-01 | |
| PCT/US2003/019046 WO2003105851A1 (en) | 2002-06-01 | 2003-06-16 | Novel crystalline forms of gatifloxacin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532364A JP2005532364A (ja) | 2005-10-27 |
| JP2005532364A5 true JP2005532364A5 (https=) | 2006-05-11 |
Family
ID=29740100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004512754A Pending JP2005532364A (ja) | 2002-06-14 | 2003-06-16 | ガチフロキサシンの新規結晶質形態 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7411067B2 (https=) |
| EP (1) | EP1471911A1 (https=) |
| JP (1) | JP2005532364A (https=) |
| CN (1) | CN1674902A (https=) |
| AU (1) | AU2003243615A1 (https=) |
| CA (1) | CA2489377A1 (https=) |
| IL (1) | IL165690A0 (https=) |
| WO (1) | WO2003105851A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118546A1 (en) * | 2004-06-04 | 2005-12-15 | Matrix Laboratories Ltd | Novel crystalline forms of gatifloxacin |
| CA2621616A1 (en) * | 2007-02-19 | 2008-08-19 | Alcon Research, Ltd. | Topical gatifloxacin formulations |
| JP2010522756A (ja) | 2007-03-29 | 2010-07-08 | プロジェニックス ファーマシューティカルズ，インコーポレーテッド | 結晶形およびその使用 |
| MY180626A (en) | 2013-11-15 | 2020-12-03 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128601C (en) | 1992-01-31 | 2003-07-15 | Hiroyuki Nagano | Quinolone carboxylic acid derivatives in crystalline hydrate form |
| JP3449658B2 (ja) | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
| US6413969B1 (en) | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
| US20060142300A1 (en) | 2002-04-08 | 2006-06-29 | Reddy Manne S | Anhydrous crystalline forms of I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1- piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) |
-
2003
- 2003-06-16 JP JP2004512754A patent/JP2005532364A/ja active Pending
- 2003-06-16 US US10/462,945 patent/US7411067B2/en not_active Expired - Fee Related
- 2003-06-16 AU AU2003243615A patent/AU2003243615A1/en not_active Abandoned
- 2003-06-16 CA CA002489377A patent/CA2489377A1/en not_active Abandoned
- 2003-06-16 EP EP03760424A patent/EP1471911A1/en not_active Withdrawn
- 2003-06-16 CN CNA038193094A patent/CN1674902A/zh active Pending
- 2003-06-16 WO PCT/US2003/019046 patent/WO2003105851A1/en not_active Ceased
-
2004
- 2004-12-09 IL IL16569004A patent/IL165690A0/xx unknown
-
2008
- 2008-07-01 US US12/217,251 patent/US20080269488A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI406661B (zh) | ４-甲基-ｎ-〔３-（４-甲基-咪唑-１-基）-５-三氟甲基-苯基〕-３-（４-吡啶-３-基-嘧啶-２基胺基）-苯甲醯胺之結晶型 | |
| CA2194984C (en) | 4-indole derivatives as serotonin agonists and antagonists | |
| JP5411734B2 (ja) | １−４−（５−シアノインドール−３−イル）ブチル−４−（２−カルバモイルベンゾフラン−５−イル）ピペラジン塩酸塩の多形相 | |
| JP4931874B2 (ja) | リモナバントの結晶多形の製造方法 | |
| TWI358296B (en) | Acid secretion inhibitor | |
| JP2020125307A (ja) | オメカムチブメカルビルの塩及び塩を調製するプロセス | |
| NO171453B (no) | Fremgangsmaate for fremstilling av krystallinsk paroxetin-hydroklorid-hemihydrat | |
| JP5656834B2 (ja) | 肥満細胞トリプターゼインヒビターとしての［４−（５−アミノメチル−２−フルオロ−フェニル）−ピペリジン−１−イル］−［７−フルオロ−１−（２−メトキシ−エチル）−４−トリフルオロメトキシ−１ｈ−インドール−３−イル］−メタノン | |
| TWI455934B (zh) | ４-甲基-ｎ-〔３-（４-甲基-咪唑-１-基）-５-三氟甲基-苯基-３-（４-吡啶-３-基-嘧啶-２-基胺基）-苯甲醯胺之鹽 | |
| CZ342896A3 (en) | Crystalline hydrochloride of (r)-(-)-2-{n-£4-(1,1-dioxido-3-oxo-2,3-dihydrobenzisothiazol-1-yl)-butyl|- -aminomethyl}-chroman, process of its preparation, pharmaceutical composition containing thereof and its use | |
| JP2001519812A (ja) | ソマトスタチン作動薬 | |
| WO1994015920A1 (en) | Benzanilide derivatives as 5-ht1d-antagonists | |
| JP2006514110A (ja) | Ｉｐ受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体 | |
| IE922523A1 (en) | New 5-isoquinolinesulfonamides process for preparing them and pharmaceutical compositions containing them | |
| HUP9903797A2 (hu) | Benzofurán-karboxamidok és -szulfonamidok, alkalmazásuk gyógyszerkészítmények előállítására és ezek a gyógyszerkészítmények | |
| JP2004527516A (ja) | ピペラジン誘導体、それらの製造方法および治療における使用（５ｈｔ１ｂ受容体活性） | |
| JP2020073513A (ja) | α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法 | |
| JP2005532364A5 (https=) | ||
| TW200922585A (en) | Amino 1,2,4-triazole derivatives as modulators of mGluR5 | |
| CN101137638A (zh) | 取代的氨基烷基-与酰氨基烷基-苯并吡喃衍生物 | |
| CA2193388C (en) | Aryl and heteroaryl alkoxynaphthalene derivatives | |
| KR102604227B1 (ko) | 리피테그라스트 결정형 및 이를 포함하는 약제학적 조성물 | |
| HU184785B (en) | Process for producing new indole derivatives | |
| FI85138C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-fenylpropylindolderivat. | |
| JP2009517431A (ja) | Ｈ３調節剤として使用するための１，１−ジオキソ−チオモルホリニルインドリルメタノン誘導体 |